About ALung
ALung is a company based in Pittsburgh (United States) founded in 1997 was acquired by LivaNova in May 2022.. ALung has raised $132.56 million across 23 funding rounds from investors including UPMC, Abiomed and LivaNova. ALung offers products and services including Essenz™ Perfusion System, VNS Therapy™ for Epilepsy, and VNS Therapy™ for Depression. ALung operates in a competitive market with competitors including Belluscura, Lungpacer, hemovent, OneBreath and Brio Device, among others.
- Headquarter Pittsburgh, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Livanova Plc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ALung
ALung offers a comprehensive portfolio of products and services, including Essenz™ Perfusion System, VNS Therapy™ for Epilepsy, and VNS Therapy™ for Depression. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
System for cardiopulmonary support during surgeries
Implantable device to treat drug-resistant epilepsy
Device for managing difficult-to-treat depression symptoms
Unlock access to complete
Unlock access to complete
Funding Insights of ALung
ALung has successfully raised a total of $132.56M across 23 strategic funding rounds. The most recent funding activity was a Series C round of $1.81 million completed in May 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 23
- Last Round Series C — $1.8M
-
First Round
First Round
(01 Jun 2002)
- Investors Count 13
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2021 | Amount | Series C - ALung | Valuation |
investors |
|
| Nov, 2020 | Amount | Series C - ALung | Valuation |
investors |
|
| Jun, 2020 | Amount | Series C - ALung | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in ALung
ALung has secured backing from 14 investors, including institutional and venture fund investors. Prominent investors backing the company include UPMC, Abiomed and LivaNova. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Venture capital is provided to high-potential tech companies in the Midwest.
|
Founded Year | Domain | Location | |
|
US focused early-stage VC firm investing in tech & life sciences start-ups
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by ALung
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - ALung
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Alung Comparisons
Competitors of ALung
ALung operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Belluscura, Lungpacer, hemovent, OneBreath and Brio Device, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Provider of medical devices for laparoscopic procedures
|
|
| domain | founded_year | HQ Location |
Neurostimulation-based pacer for diaphragm strength is developed.
|
|
| domain | founded_year | HQ Location |
Equipment for extracorporeal life support and CO2 removal is developed.
|
|
| domain | founded_year | HQ Location |
Portable mechanical ventilators for intensive care patients are developed.
|
|
| domain | founded_year | HQ Location |
Medical devices for emergency airway management are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Alung
Frequently Asked Questions about ALung
When was ALung founded?
ALung was founded in 1997 and raised its 1st funding round 5 years after it was founded.
Where is ALung located?
ALung is headquartered in Pittsburgh, United States. It is registered at Pittsburgh, Pennsylvania, United States.
Is ALung a funded company?
ALung is a funded company, having raised a total of $132.56M across 23 funding rounds to date. The company's 1st funding round was a Series C of $2M, raised on Jun 01, 2002.
What does ALung do?
ALung was founded in 1997 in Pittsburgh, United States, and operates within the medical technology sector. Extracorporeal CO2 removal systems are developed to support mechanical ventilation for patients. The Hemolung Cartridge is integrated with a centrifugal blood pump and gas exchange membrane as a single device. Focus is placed on respiratory assistance technologies, with headquarters maintained in Pittsburgh.
Who are the top competitors of ALung?
ALung's top competitors include Belluscura, Lungpacer and hemovent.
What products or services does ALung offer?
ALung offers Essenz™ Perfusion System, VNS Therapy™ for Epilepsy, and VNS Therapy™ for Depression.
Who are ALung's investors?
ALung has 14 investors. Key investors include UPMC, Abiomed, LivaNova, West Capital Advisors, and Pittsburgh Life Sciences Greenhouse.